Hutch News

Alcohol, cannabis use after cancer: ‘eye-opening’ prevalence

Alcohol, cannabis use after cancer: ‘eye-opening’ prevalence

Fred Hutch researchers surprised after digging into patients’ use of substances after diagnosis
Hutch NewsApril 05, 2024
Microbial cell-free DNA may help predict transplantation outcomes

Microbial cell-free DNA may help predict transplantation outcomes

From the Markey Lab, Translational Science and Therapeutics Division
Science SpotlightJanuary 22, 2024
2 women with breast cancer share their perspectives on living with the disease

2 women with breast cancer share their perspectives on living with the disease

During Breast Cancer Awareness Month, Leah Marcoe and Maria Pearson reflect on their experiences
Hutch NewsOctober 18, 2023
Hidden in plain sight: addition of race and ethnicity improves clinical algorithm performance

Hidden in plain sight: addition of race and ethnicity improves clinical algorithm performance

From the Bansal lab, Public Health Sciences Division
Science SpotlightAugust 21, 2023
Pinpointing pain: Is it cancer or cancer treatment?

Pinpointing pain: Is it cancer or cancer treatment?

Distinguishing side effects of treatment from a potential metastatic recurrence can be tricky; we asked cancer experts for their best advice
Hutch NewsJune 05, 2023
A new blood test detects recurrence of rare skin cancer

A new blood test detects recurrence of rare skin cancer

$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging
Hutch NewsDecember 12, 2016
Drinking after breast cancer won’t raise mortality risk, study shows

Drinking after breast cancer won’t raise mortality risk, study shows

Alcohol use after breast cancer doesn’t increase your chances of dying of the disease, new study shows, but it does increase overall cancer risk
Hutch NewsJune 10, 2016
High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse

High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse

Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
Hutch NewsMay 21, 2012